"Olympian Clinical Research (formerly Academic Alliance for Clinical Research) is a locally owned research group, founded in 2007 in Tampa, FL by Dr. Panos Vasiloudes. Our group conducts numerous FDA sponsored clinical research studies in hopes of expediting the approval of new treatment options. Participation in a clinical research study provides the opportunity to our patients to receive cutting edge treatment options often unavailable outside of a clinical research study."

During the past decade, Olympian Clinical Research conducted 67 clinical trials. In the 10-year time frame, 67 clinical trials started and 48 clinical trials were completed, i.e. on average, 71.6% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 39 clinical trials were completed. i.e. 195% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Olympian Clinical Research" #1 sponsor was "Pfizer" with 18 trials, followed by "Eli Lilly and Company" with 9 trials sponsored, "Incyte Corporation" with 5 trials sponsored, "Janssen Research & Development, LLC" with 5 trials sponsored and "Bristol-Myers Squibb" with 5 trials sponsored. Other sponsors include 34 different institutions and companies that sponsored additional 37 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Olympian Clinical Research" #1 collaborator was "Dermira, Inc." with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator and "Athenex, Inc." with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Olympian Clinical Research" are "Atopic Dermatitis" (21 trials), "Psoriasis" (8 trials), "Plaque Psoriasis" (6 trials), "Dermatitis, Atopic" (5 trials) and "Depressive Disorder, Major" (4 trials). Many other conditions were trialed in "Olympian Clinical Research" in a lesser frequency.

Most popular intervention types in "Olympian Clinical Research" are "Drug" (71 trials), "Other" (6 trials), "Biological" (5 trials), "Combination Product" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (41 trials), "Vehicle" (5 trials), "Lebrikizumab" (4 trials), "PF-04965842 100 mg" (4 trials) and "PF-04965842 200 mg" (4 trials). Other intervention names were less common.

The vast majority of trials in "Olympian Clinical Research" are 74 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Olympian Clinical Research". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 63 completed trials in Olympian Clinical Research, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Olympian Clinical Research, 3 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 44 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".